Cordiamine, 250 mg/ml 2 ml 10 pcs

Asphyxia, cardiac arrest, shock; narcotics, poisoning, sleeping pills, analgesics.

Indications

Asphyxia, cardiac dysfunction, shock; narcotics, poisoning, sleeping pills, analgesics.

Pharmacological effect

Pharmacotherapeutic group.

Special instructions

Convulsions are possible with an overdose of niketamide.

Active ingredient

Niketamide

Composition

1 ml of the drug contains:

active ingredient – niketamide 250.0 mg;

excipient – water for injection up to 1.0 ml.

Pregnancy

There is no reliable data on the safety of using the drug during
pregnancy and lactation. It is not recommended to use this drug in
period of pregnancy and lactation.

Contraindications

Epilepsy, hypersensitivity, hyperthermia in children, a history of tonic-clonic seizures.

Side Effects

From the digestive system: vomiting.

Interaction

The convulsive effect of cordiamine is enhanced by reserpine, the stimulating effect on the respiratory center is eliminated by anesthesia, the effect of the drug is weakened by saluzide and PAS, aminazine and the analeptic effect and other phenothiazine derivatives lead to a weakening of the convulsive effect.

Overdose

Symptoms of overdose: increased severity of dose-dependent side effects, generalized tonic-clonic convulsions.

Measures to assist in case of overdose: symptomatic treatment (including anticonvulsants).

Storage conditions

In a place protected from light, at a temperature not exceeding 15 °C.

Shelf life

3 years.

Manufacturer

Dalkhimfarm, Russia